JP4874514B2 - Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof - Google Patents

Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof Download PDF

Info

Publication number
JP4874514B2
JP4874514B2 JP2003405201A JP2003405201A JP4874514B2 JP 4874514 B2 JP4874514 B2 JP 4874514B2 JP 2003405201 A JP2003405201 A JP 2003405201A JP 2003405201 A JP2003405201 A JP 2003405201A JP 4874514 B2 JP4874514 B2 JP 4874514B2
Authority
JP
Japan
Prior art keywords
cells
stratified
cell sheet
epithelial cells
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003405201A
Other languages
Japanese (ja)
Other versions
JP2005130838A (en
Inventor
幸二 西田
雅之 大和
光夫 岡野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellseed Inc
Original Assignee
Cellseed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellseed Inc filed Critical Cellseed Inc
Priority to JP2003405201A priority Critical patent/JP4874514B2/en
Publication of JP2005130838A publication Critical patent/JP2005130838A/en
Application granted granted Critical
Publication of JP4874514B2 publication Critical patent/JP4874514B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Description

本発明は、生物学、医学等の分野における上皮系細胞の重層化培養方法、それから得られる重層化上皮系細胞シート及びその利用方法に関する。  The present invention relates to a stratified culture method for epithelial cells in fields such as biology and medicine, a stratified epithelial cell sheet obtained therefrom, and a method for using the same.

医療技術の著しい発展により、近年、治療困難となった臓器を他人の臓器と置き換えようとする臓器移植が一般化してきた。対象となる臓器も皮膚、角膜、腎臓、肝臓、心臓等と実に多様で、また、術後の経過も格段に良くなり、医療の一技術としてすでに確立されつつある。一例として角膜移植をあげると、約40年前に日本にもアイバンクが設立され移植活動が始められた。しかしながら、未だにドナー数が少なく、国内だけでも角膜移植の必要な患者が年間約2万人出てくるのに対し、実際に移植治療が行える患者は約1/10の2000人程度でしかないといわれている。角膜移植というほぼ確立された技術があるにもかかわらず、ドナー不足という問題のため、次なる医療技術が求められているのが現状である。  Due to the remarkable development of medical technology, in recent years, organ transplants that attempt to replace difficult-to-treat organs with other organs have become common. The target organs are very diverse, such as skin, cornea, kidney, liver, heart, etc., and the progress after surgery has improved remarkably, and has already been established as a medical technology. Taking corneal transplantation as an example, an eye bank was established in Japan about 40 years ago and transplantation activities began. However, the number of donors is still small, and there are about 20,000 patients who need corneal transplantation in Japan alone, whereas only about 1/10 patients who can actually undergo transplantation treatment are about 2000. It is said. Despite the almost established technology of corneal transplantation, the current situation is that the next medical technology is required due to the shortage of donors.

このような背景のもと、以前より、人工代替物や細胞を培養して組織化させたものをそのまま移植しようという技術が注目されている。その代表的な例として、人工皮膚及び培養皮膚があげられよう。しかしながら、合成高分子を用いた人工皮膚は拒絶反応等が生じる可能性があり、移植用皮膚としては好ましくない。一方、培養皮膚は本人の正常な皮膚の一部を所望の大きさまで培養したものであるため、これを使用しても拒絶反応等の心配がなく、最も自然なマスキング剤と言える。  Against this background, techniques for transplanting artificial substitutes or cells that have been cultured and organized have attracted attention. Representative examples thereof include artificial skin and cultured skin. However, artificial skin using a synthetic polymer may cause rejection and the like, and is not preferable as skin for transplantation. On the other hand, since the cultured skin is obtained by culturing a part of the normal skin of the person to a desired size, even if it is used, there is no concern about rejection or the like, and it can be said to be the most natural masking agent.

特公平2−23191号公報には、ヒト新生児由来表皮角化細胞を、ケラチン組織の膜が容器表面上に形成される条件下で培養し、生成したケラチン組織膜を酵素を用いて剥離させることを特徴とする移植可能な培養細胞膜を製造する方法が記載されている。具体的には、3T3細胞をフィーダーレイヤーとして用いることで、播種した表皮細胞は増殖し、しかもそのまま重層化してしまうというものである。この方法は、今や表皮角化細胞を培養する方法の主流にまでなっている。しかしながら、この方法には欠点があり、すなわち上記3T3細胞がマウス由来の細胞である点がよく指摘される。一般的には、表皮角化細胞を培養している間にこの3T3細胞は消失すると言われているが、未だに100%消失したことを証明することができていないのが現状である。  Japanese Patent Publication No. 2-23191 discloses culturing epidermis keratinocytes derived from human newborns under conditions in which a keratinous tissue film is formed on the surface of a container, and peeling off the produced keratinous tissue membrane using an enzyme. A method for producing transplantable cultured cell membranes is described. Specifically, by using 3T3 cells as a feeder layer, the seeded epidermal cells proliferate and stratify as they are. This method has now become the mainstream method for culturing epidermal keratinocytes. However, it is often pointed out that this method has drawbacks, that is, the 3T3 cells are mouse-derived cells. In general, it is said that the 3T3 cells disappear while culturing epidermal keratinocytes, but it is still impossible to prove that they have disappeared 100%.

この点を解決すべく、これまでに種々の検討がなされてきた。例えば、別の培養基材上で3T3細胞を培養し、表皮角化細胞に有効な物質を培地中に出させ、その上清だけを表皮角化細胞を培養している系に移す方法があげられる(特開平9−313172号、特開2001−149070号)。しかしながら、この方法でも、異種動物の細胞自身の混入は防げても、異種動物細胞が産生するさまざまな蛋白質を分割している訳でなく、基本的に同様な問題が残されている。その他に、ヒト由来の細胞をフィーダーレイヤーとして利用しようとする試みもなされているが、未だに上記3T3細胞並みの活性を持った細胞が得られておらず、3T3細胞に代わる有効な技術が強く望まれていた。  In order to solve this problem, various studies have been made so far. For example, 3T3 cells are cultured on another culture substrate, a substance effective for epidermal keratinocytes is put into the medium, and only the supernatant is transferred to a system in which epidermal keratinocytes are cultured. (JP-A-9-313172, JP-A-2001-149070). However, even in this method, even though the contamination of the cells of the heterologous animal itself is prevented, the various proteins produced by the heterologous animal cells are not divided, and basically the same problem remains. In addition, attempts have been made to use human-derived cells as a feeder layer. However, cells having the same activity as 3T3 cells have not been obtained yet, and an effective technique to replace 3T3 cells is strongly desired. It was rare.

本発明は、上記のような従来技術の問題点を解決することを意図してなされたものである。すなわち、本発明は、従来技術と全く異なった発想からの新規な上皮系細胞の重層化培養方法及びそれから得られる重層化上皮系細胞シートを提供することを目的とする。また、本発明は、その利用方法を提供することを目的とする。  The present invention has been made with the intention of solving the problems of the prior art as described above. That is, an object of the present invention is to provide a novel stratified culture method of epithelial cells from a completely different idea from the prior art and a stratified epithelial cell sheet obtained therefrom. Moreover, an object of this invention is to provide the utilization method.

本発明者らは、上記課題を解決するために、種々の角度から検討を加えて、研究開発を行った。その結果、驚くべくことに、上皮系細胞を多孔膜上で培養させ、その多孔膜を境に上層部及び下層部の双方を培地で満たし、細胞が培養されている間、常に多孔膜を介して培地が下層から供給されれば上皮系細胞が重層化されることを見出した。また、多孔膜下層部の培養床に細胞外マトリックス層を設け、その内部または上部、或いはその双方にフィーダー細胞を培養しても上皮系細胞が重層化されることを見出した。さらに、多孔膜表面に水に対する上限もしくは下限臨界溶解温度が0〜80℃である温度応答性高分子を被覆し、その上で上皮系細胞が培養され、重層化させた後、培養液温度を上限臨界溶解温度以上または下限臨界溶解温度以下とし、培養した角膜上皮細胞シートまたはその重層化シートをキャリアに密着させれば、そのままキャリアと共に剥離させられることを見出した。本発明はかかる知見に基づいて完成されたものである。  In order to solve the above-mentioned problems, the present inventors have studied and developed from various angles. As a result, surprisingly, epithelial cells are cultured on the porous membrane, and both the upper layer and the lower layer are filled with the medium with the porous membrane as a boundary. It was found that epithelial cells are stratified if the medium is supplied from the lower layer. Further, it has been found that even when an extracellular matrix layer is provided on the culture bed of the lower layer of the porous membrane, and feeder cells are cultured in or on the inside, the epithelial cells are stratified. Further, the surface of the porous membrane is coated with a temperature-responsive polymer having an upper or lower critical solution temperature of 0 to 80 ° C., and epithelial cells are cultured and layered thereon, and then the temperature of the culture solution is set. It has been found that if the cultured corneal epithelial cell sheet or its stratified sheet is brought into close contact with the carrier, it can be peeled off as it is together with the carrier. The present invention has been completed based on such findings.

すなわち、本発明は、上皮系細胞を多孔膜上で培養させる際、その多孔膜を境に上層部及び下層部の双方を培地で満たし、細胞が培養されている間は常に多孔膜を介して培地が下層から細胞に供給されている上皮系細胞の重層化培養方法を提供する。
また、本発明は、多孔膜下層部の培養床に細胞外マトリックス層を設け、その内部または上部、或いはその双方にフィーダー細胞を培養することを特徴とする上皮系細胞の重層化培養方法を提供する。
さらに、本発明は、多孔膜表面に水に対する上限もしくは下限臨界溶解温度が0〜80℃である温度応答性高分子を被覆し、その上で上皮系細胞が培養され、重層化させた後、
(1)培養液温度を上限臨界溶解温度以上または下限臨界溶解温度以下とし、
(2)培養した角膜上皮細胞シートまたはその重層化シートをキャリアに密着させ、
(3)そのままキャリアと共に剥離する
ことを特徴とする上皮系細胞の重層化培養方法を提案する。
加えて、本発明は、上記方法で得られた重層化上皮系細胞シートを提供する。
さらに加えて、本発明は、組織の一部或いは全部を損傷もしくは欠損した患部に対し、上記重層化上皮系細胞シートを移植することを特徴とする治療法を提供する。
That is, when culturing epithelial cells on a porous membrane, the present invention fills both the upper layer portion and the lower layer portion with the medium with the porous membrane as a boundary, and always passes through the porous membrane while the cells are cultured. Provided is a method for stratifying culture of epithelial cells in which a medium is supplied to cells from the lower layer.
The present invention also provides an epithelial cell stratification culture method characterized in that an extracellular matrix layer is provided on a culture bed of a porous membrane lower layer portion, and feeder cells are cultured inside, on or both of them. To do.
Furthermore, the present invention covers the surface of the porous membrane with a temperature-responsive polymer having an upper or lower critical solution temperature of 0 to 80 ° C. with respect to water, on which epithelial cells are cultured and layered,
(1) The culture solution temperature is set to the upper critical solution temperature or higher or the lower critical solution temperature or lower,
(2) Adhering the cultured corneal epithelial cell sheet or its multilayered sheet to a carrier,
(3) A layered culture method for epithelial cells, characterized in that it is peeled off together with the carrier, is proposed.
In addition, the present invention provides a stratified epithelial cell sheet obtained by the above method.
In addition, the present invention provides a treatment method characterized by transplanting the above-mentioned stratified epithelial cell sheet to an affected part in which a part or all of a tissue is damaged or lost.

本発明に記載される方法であれば、上皮系細胞を多孔膜上で培養することでフィーダー細胞を用いることなく重層化させられる。また、フィーダー細胞を細胞外マトリックスと共に培養することでフィーダー細胞を何ら変性させることなく上皮系細胞を重層化させられる。さらに、上記多孔膜上に温度応答性高分子を被覆すれば、冷却のみで重層化させた上皮系細胞を剥離させることができ、そのため生体組織への生着性が極めて高い高生着性の重層化上皮系細胞シートが得られるようになる。  According to the method described in the present invention, epithelial cells are cultured on a porous membrane to be layered without using feeder cells. In addition, by culturing feeder cells with an extracellular matrix, epithelial cells can be stratified without any degeneration of the feeder cells. Furthermore, if a temperature-responsive polymer is coated on the porous membrane, the epithelial cells that have been stratified only by cooling can be detached, and therefore, a highly encapsulated stratification that has extremely high engraftment to living tissue. The epithelial cell sheet can be obtained.

本発明は、上皮系細胞を多孔膜上で培養させる際、その多孔膜を境に上層部及び下層部の双方を培地で満たし、細胞が培養されている間は常に多孔膜を介して培地が下層から細胞に供給されていることを特徴とする上皮系細胞の重層化培養方法を提供する。その際、下層部に上皮系細胞を分化または維持させるためのフィーダー細胞を培養しても、或いは培養しなくても特に制約されるものではないが、本発明の方法に従えばフィーダー細胞を用いずに培養でき、製造上の効率、或いはフィーダー細胞のコンタミネーションを防ぐことができ好ましい。  In the present invention, when epithelial cells are cultured on a porous membrane, both the upper layer and the lower layer are filled with the medium with the porous membrane as a boundary, and the medium always passes through the porous membrane while the cells are cultured. An epithelial cell stratification culture method characterized by being supplied to cells from a lower layer. At that time, it is not particularly limited whether feeder cells for differentiating or maintaining epithelial cells in the lower layer are cultured or not, but according to the method of the present invention, feeder cells are used. It is preferable that the cells can be cultured without manufacturing, and manufacturing efficiency or contamination of feeder cells can be prevented.

本発明に使用される好適な上皮系細胞として、たとえば角膜上皮細胞、表皮角化細胞、口腔粘膜細胞、結膜上皮細胞のいずれかもしくは2者以上の混合物が挙げられるが、その種類は、何ら制約されるものではない。また、その上皮系細胞の由来は特に制約されるものではないが、たとえばヒト、イヌ、ネコ、ウサギ、ラット、ブタ、ヒツジなどが挙げられるが、本発明の重層化上皮系細胞シートをヒトの治療に用いる場合はヒト由来の細胞を用いる方が望ましい。  Suitable epithelial cells used in the present invention include, for example, corneal epithelial cells, epidermal keratinocytes, oral mucosal cells, conjunctival epithelial cells, or a mixture of two or more, but the type is not limited. Is not to be done. The origin of the epithelial cells is not particularly limited, and examples thereof include humans, dogs, cats, rabbits, rats, pigs, sheep and the like. When using for treatment, it is desirable to use human-derived cells.

本発明における細胞培養のための培地は培養される細胞に対し通常用いられるものを用いれば特に制約されるものではないが、得られた重層化上皮系細胞シートをヒトの治療に用いる場合は用いる培地の成分は由来が明確なもの、もしくは医薬品として認められているものが望ましい。本発明ではこの培地を上皮系細胞が培養される多孔膜を介して上層及び下層に満たして行われる。この方法であれば、多孔膜上の上皮系細胞は上層にある培地だけでなく、下層部の培地も供給されることとなる。現時点では、詳細な理由は明らかになっていないが、この下層部からの十分な培地の供給が上皮系細胞の重層化に有用であるものと考えられる。  The culture medium for cell culture in the present invention is not particularly limited as long as it is a commonly used medium for cells to be cultured, but is used when the obtained stratified epithelial cell sheet is used for human therapy. It is desirable that the medium components have a clear origin or are recognized as pharmaceuticals. In the present invention, this medium is filled with the upper and lower layers through a porous membrane in which epithelial cells are cultured. In this method, epithelial cells on the porous membrane are supplied not only with the medium in the upper layer but also with the medium in the lower layer. Although the detailed reason has not been clarified at this time, it is considered that supply of a sufficient medium from the lower layer is useful for stratification of epithelial cells.

また、本発明は、多孔膜下層部の培養床に細胞外マトリックス層を設け、その内部または上部、或いはその双方にフィーダー細胞を培養する上皮系細胞の重層化培養方法を提供する。この方法に従えば、フィーダー細胞を何ら変性させなくてもフィーダー細胞は増殖しなくなり、多孔膜上に培養された上皮系細胞が重層化する際に有用な物質を生産し続けることを見いだした。この方法は、従来、フィーダー細胞の増殖性を抑えるために行われていたマイトマイシンC処理やエックス線、ガンマ線処理を必要とせず、培養時の操作性が簡便になること、マイトマイシンCなどの本来細胞培養で使われないような薬物のコンタミネーションがなくなること、或いはエックス線、ガンマ線処理などといった大掛かりな作業も不要となり好ましい。本発明に使用される細胞外マトリックスとして、たとえばコラーゲン、ラミニン、フィブロネクチンのいずれかもしくは2者以上の混合物が挙げられるが、その種類は、何ら制約されるものではない。本発明に使用される細胞外マトリックスの被覆量及びその被覆方法は特に制約されたものではなく、常法に従って、ゲル化させたり、細胞外マトリックス溶液を乾固させれば良い。  The present invention also provides an epithelial cell stratification culture method in which an extracellular matrix layer is provided on a culture bed in a lower layer of a porous membrane, and feeder cells are cultured inside, on or both. According to this method, it has been found that the feeder cells do not proliferate without any modification of the feeder cells, and continue to produce useful substances when the epithelial cells cultured on the porous membrane are layered. This method does not require mitomycin C treatment, X-ray, or gamma ray treatment, which has been conventionally performed in order to suppress the proliferation of feeder cells, simplifies the operability during cultivation, and originally cultivates cell culture such as mitomycin C. This is preferable because there is no contamination of drugs that are not used in the field, and large-scale operations such as X-ray and gamma ray processing are unnecessary. Examples of the extracellular matrix used in the present invention include any one of collagen, laminin, fibronectin, or a mixture of two or more, but the type is not limited. The coating amount of the extracellular matrix and the coating method used in the present invention are not particularly limited, and may be gelled or the extracellular matrix solution may be solidified according to a conventional method.

本発明で使用されるフィーダー細胞としては、たとえば線維芽細胞、組織幹細胞、胚性幹細胞などが挙げられるが、特に制約されるものではない。また、上皮系細胞とフィーダー細胞は必ずしも同一種の動物由来のもので良いが、得られた重層化上皮系細胞シートを移植に用いる場合は上皮系細胞とフィーダー細胞を同一種の動物由来のものとした方が望ましい。また、この重層化上皮系細胞シートをヒトの治療に用いる場合は上皮系細胞とフィーダー細胞をヒト由来の細胞を用いる方が望ましい。  Examples of feeder cells used in the present invention include fibroblasts, tissue stem cells, and embryonic stem cells, but are not particularly limited. In addition, epithelial cells and feeder cells may be derived from the same species of animal, but when the obtained stratified epithelial cell sheet is used for transplantation, epithelial cells and feeder cells are derived from the same species of animal. It is more desirable. In addition, when this stratified epithelial cell sheet is used for human therapy, it is desirable to use human-derived cells for epithelial cells and feeder cells.

多孔膜表面において被覆に用いられる温度応答性ポリマーは、水溶液中で上限臨界溶解温度または下限臨界溶解温度0℃〜80℃、より好ましくは20℃〜50℃を有する。上限臨界溶解温度または下限臨界溶解温度が80℃を越えると細胞が死滅する可能性があるので好ましくない。また、上限臨界溶解温度または下限臨界溶解温度が0℃より低いと一般に細胞増殖速度が極度に低下するか、または細胞が死滅してしまうため、やはり好ましくない。  The temperature-responsive polymer used for coating on the surface of the porous membrane has an upper critical solution temperature or a lower critical solution temperature of 0 ° C to 80 ° C, more preferably 20 ° C to 50 ° C in an aqueous solution. If the upper critical lysis temperature or the lower critical lysis temperature exceeds 80 ° C., the cells may die, which is not preferable. Further, when the upper critical lysis temperature or the lower critical lysis temperature is lower than 0 ° C., the cell growth rate is generally extremely reduced or the cells are killed, which is also not preferable.

本発明に用いる温度応答性高分子はホモポリマー、コポリマーのいずれであってもよい。このような高分子としては、例えば、特開平2−211865号公報に記載されているポリマーが挙げられる。具体的には、例えば、以下のモノマーの単独重合または共重合によって得られる。使用し得るモノマーとしては、例えば、(メタ)アクリルアミド化合物、N−(若しくはN,N−ジ)アルキル置換(メタ)アクリルアミド誘導体、またはビニルエーテル誘導体が挙げられ、コポリマーの場合は、これらの中で任意の2種以上を使用することができる。更には、上記モノマー以外のモノマー類との共重合、ポリマー同士のグラフトまたは共重合、あるいはポリマー、コポリマーの混合物を用いてもよい。また、ポリマー本来の性質を損なわない範囲で架橋することも可能である。  The temperature-responsive polymer used in the present invention may be either a homopolymer or a copolymer. Examples of such a polymer include polymers described in JP-A-2-21865. Specifically, for example, it can be obtained by homopolymerization or copolymerization of the following monomers. Examples of the monomer that can be used include a (meth) acrylamide compound, an N- (or N, N-di) alkyl-substituted (meth) acrylamide derivative, or a vinyl ether derivative. Two or more of these can be used. Furthermore, copolymerization with monomers other than the above monomers, grafting or copolymerization of polymers, or a mixture of polymers and copolymers may be used. Moreover, it is also possible to crosslink within a range that does not impair the original properties of the polymer.

温度応答性高分子の多孔膜への被覆方法は、特に制限されないが、例えば、特開平2−211865号公報に記載されている方法に従ってよい。すなわち、かかる被覆は、基材と上記モノマーまたは高分子を、電子線照射(EB)、γ線照射、紫外線照射、プラズマ処理、コロナ処理、有機重合反応のいずれかにより、または塗布、混練等の物理的吸着等により行うことができる。温度応答性高分子の被覆量は、0.4〜4.5μg/cmの範囲が良く、好ましくは0.7〜3.5μg/cmであり、さらに好ましくは0.9〜3.0μg/cmである。0.2μg/cmより少ない被覆量のとき、刺激を与えても当該高分子上の細胞は剥離し難く、作業効率が著しく悪くなり好ましくない。逆に4.5μg/cm以上であると、その領域に細胞が付着し難く、細胞を十分に付着させることが困難となる。The method for coating the porous film with the temperature-responsive polymer is not particularly limited, and for example, a method described in JP-A-2-21865 may be used. That is, the coating is performed by applying the substrate and the monomer or polymer to one of electron beam irradiation (EB), γ-ray irradiation, ultraviolet irradiation, plasma treatment, corona treatment, organic polymerization reaction, coating, kneading, etc. It can be performed by physical adsorption or the like. The coverage of the temperature responsive polymer may have a range of 0.4~4.5μg / cm 2, preferably 0.7~3.5μg / cm 2, more preferably 0.9~3.0μg / Cm 2 . When the coating amount is less than 0.2 μg / cm 2 , the cells on the polymer are difficult to peel off even when a stimulus is applied, and the working efficiency is remarkably deteriorated. On the other hand, if it is 4.5 μg / cm 2 or more, it is difficult for cells to adhere to the region, and it becomes difficult to sufficiently attach the cells.

本発明における多孔膜の形態は特に制約されるものではないが、例えばセルインサートのような形態のもの、或いは平膜状のものなどが挙げられる。その際、上皮系細胞は多孔膜上層で培養される必要性がある。  The form of the porous film in the present invention is not particularly limited, and examples thereof include a form like a cell insert or a flat film form. At that time, epithelial cells need to be cultured in the upper layer of the porous membrane.

本発明において、上皮系細胞の培養は上述のようにして製造された多孔膜上で行われる。培地温度は、多孔膜表面に被覆された前記高分子が上限臨界溶解温度を有する場合はその温度以下、また前記高分子が下限臨界溶解温度を有する場合はその温度以上であれば特に制限されない。しかし、培養細胞が増殖しないような低温域、あるいは培養細胞が死滅するような高温域における培養が不適切であることは言うまでもない。温度以外の培養条件は、常法に従えばよく、特に制限されるものではない。例えば、使用する培地については、公知のウシ胎児血清(FCS)等の血清が添加されている培地でもよく、また、このような血清が添加されていない無血清培地でもよい。  In the present invention, epithelial cells are cultured on the porous membrane produced as described above. The medium temperature is not particularly limited as long as the polymer coated on the porous membrane surface has an upper critical solution temperature or lower, and when the polymer has a lower critical solution temperature or higher, the medium temperature is not particularly limited. However, it goes without saying that culturing in a low temperature range where cultured cells do not proliferate or in a high temperature range where cultured cells die is inappropriate. The culture conditions other than the temperature may be in accordance with conventional methods and are not particularly limited. For example, the medium to be used may be a medium to which serum such as known fetal calf serum (FCS) is added, or a serum-free medium to which such serum is not added.

本発明の方法において、重層化した上皮系細胞を多孔膜から剥離回収するには、培養された上皮系細胞シートをキャリアに密着させ、細胞の付着した支持体材料の温度を支持体基材の被覆高分子の上限臨界溶解温度以上若しくは下限臨界溶解温度以下にすることによって、そのままキャリアとともに剥離することができる。なお、シートを剥離することは細胞を培養していた培養液中において行うことも、その他の等張液中において行うことも可能であり、目的に合わせて選択することができる。また、その重層化シートを高収率で剥離、回収する目的で、細胞培養支持体を軽くたたいたり、ゆらしたりする方法、更にはピペットを用いて培地を撹拌する方法等を単独で、あるいは併用して用いてもよい。加えて、必要に応じて培養細胞は等張液等で洗浄して剥離回収してもよい。  In the method of the present invention, in order to peel and collect the stratified epithelial cells from the porous membrane, the cultured epithelial cell sheet is brought into close contact with the carrier, and the temperature of the support material to which the cells are attached is adjusted to the temperature of the support substrate. By making the temperature higher than the upper critical solution temperature or lower than the lower critical solution temperature of the coating polymer, it can be peeled off together with the carrier. Note that peeling of the sheet can be performed in a culture solution in which cells are cultured or in another isotonic solution, and can be selected according to the purpose. In addition, for the purpose of peeling and collecting the multi-layered sheet at a high yield, a method of gently tapping or shaking the cell culture support, a method of stirring the medium using a pipette, etc. alone, or You may use together. In addition, the cultured cells may be separated and recovered by washing with an isotonic solution or the like as necessary.

そのキャリアとは、例えば、高分子膜または高分子膜から成型された構造物、金属性治具などを使用することができる。例えば、キャリアの材質として高分子を使用する場合、その具体的な材質としてはポリビニリデンジフルオライド(PVDF)、ポリプロピレン、ポリエチレン、セルロース及びその誘導体、紙類、キチン、キトサン、コラーゲン、ウレタン等を挙げることができる。  As the carrier, for example, a polymer film, a structure molded from the polymer film, a metallic jig, or the like can be used. For example, when a polymer is used as the carrier material, specific examples of the material include polyvinylidene difluoride (PVDF), polypropylene, polyethylene, cellulose and derivatives thereof, papers, chitin, chitosan, collagen, urethane, and the like. Can be mentioned.

キャリアの形状は、特に限定されるものではないが、例えば得られた重層化上皮系細胞シートを移植する際に、キャリアの一部に移植部位と同程度もしくは移植部位より大きく切り拔いたものを利用すると、重層化上皮系細胞シートは切り拔かれたの周囲の部分だけに固定され、切り抜かれた部分にある細胞シートを移植部位に当てるだけで良く、好都合である。  The shape of the carrier is not particularly limited. For example, when the obtained stratified epithelial cell sheet is transplanted, a part of the carrier that is cut to the same extent as the transplant site or larger than the transplant site is used. When used, the stratified epithelial cell sheet is conveniently fixed only to the peripheral part of the cut-out, and it is only necessary to apply the cell sheet in the cut-out part to the transplantation site.

本発明における重層化上皮系細胞シートは培養時にディスパーゼ、トリプシン等で代表される蛋白質分解酵素による損傷を受けていないものである。そのため、基材から剥離された重層化上皮系細胞シートは、細胞−細胞間のデスモソーム構造が保持され、構造的欠陥が少なく、強度の高いものである。また、本発明のシートは培養時に形成される細胞−基材間の基底膜様蛋白質も酵素による破壊を受けていない。このことにより、移植時において患部組織と良好に接着することができ、効率良い治療を実施することができるようになる。以上のことを具体的に説明すると、トリプシン等の通常の蛋白質分解酵素を使用した場合、細胞−細胞間のデスモソーム構造及び細胞、基材間の基底膜様蛋白質等は殆ど保持されておらず、従って、細胞は個々に分かれた状態となって剥離される。その中で、蛋白質分解酵素であるディスパーゼに関しては、細胞−細胞間のデスモソーム構造については10〜60%保持した状態で剥離させることができることで知られているが、細胞−基材間の基底膜様蛋白質等を殆ど破壊してしまうため、得られる細胞シートは強度の弱いものである。これに対して、本発明の細胞シートは、デスモソーム構造、基底膜様蛋白質共に80%以上残存された状態のものであり、上述したような種々の効果を得ることができるものである。  The stratified epithelial cell sheet in the present invention is not damaged by proteolytic enzymes represented by dispase, trypsin and the like at the time of culture. For this reason, the stratified epithelial cell sheet peeled from the base material has a high strength because the cell-cell desmosome structure is maintained, there are few structural defects. In addition, in the sheet of the present invention, the basement membrane-like protein between the cell and the substrate formed during the culture is not damaged by the enzyme. As a result, it is possible to adhere well to the affected tissue at the time of transplantation, and an efficient treatment can be performed. Specifically, when using a normal proteolytic enzyme such as trypsin, the cell-cell desmosome structure and the cell, the basement membrane-like protein between the substrates is hardly retained, Therefore, the cells are separated and separated in an individual state. Among them, dispase, a proteolytic enzyme, is known to be able to be detached in a state where the cell-cell desmosome structure is maintained at 10 to 60%. The obtained cell sheet is weak because it almost destroys the protein. In contrast, the cell sheet of the present invention is in a state where 80% or more of the desmosome structure and the basement membrane-like protein remain, and can obtain various effects as described above.

本発明では、重層化上皮系細胞シートを患部に当てた後、細胞シートをキャリアからはがせば良い。そのはがし方は、何ら制約されるものではないが、例えば、キャリアを濡らしてキャリアと細胞シートの密着性を弱めてはがす方法、或いはメス、はさみ、レーザー光、プラズマ波などの治具を用いても切断する方法でも良い。例えば上述したような一部を切り抜いたキャリアに密着した細胞シートを用いた場合、レーザー光などを用いて患部の境界線に沿って切断すると患部以外の余計なところへの細胞シートの付着を避けられ好都合である。  In the present invention, the cell sheet may be peeled off from the carrier after applying the stratified epithelial cell sheet to the affected area. The method of peeling is not limited at all, but for example, a method of wetting the carrier to weaken the adhesion between the carrier and the cell sheet, or using a knife such as a knife, scissors, laser light, plasma wave, etc. Also, a method of cutting may be used. For example, when using a cell sheet that is in close contact with a carrier that has been partially cut out as described above, cutting along the boundary line of the affected area using laser light or the like avoids attachment of the cell sheet to an extra area other than the affected area. It is convenient.

本発明で示すところの重層化上皮系細胞シートと生体組織との固定方法は特に限定されるものではなく、細胞シートと生体組織を縫合しても良く、或いは本発明で示すところの重層化上皮系細胞シートは生体組織と速やかに生着するため、患部に付着させた細胞シートは生体側と縫合しなくても良い。  The fixing method of the stratified epithelial cell sheet and the biological tissue shown in the present invention is not particularly limited, and the cell sheet and the biological tissue may be sutured, or the stratified epithelium as shown in the present invention. Since the cell sheet adheres quickly to the living tissue, the cell sheet attached to the affected part does not need to be sutured to the living body side.

本発明で示される重層化上皮系細胞シートの用途は、何ら制約されるものではないが、例えば火傷、瘢痕、あざ、角膜びらん、角膜潰瘍などの治療、或いはエキシマレーザーを中央部に照射して角膜表面を削り、角膜の屈折力を減少させて近視を矯正するピーアールケー(PRK)法、マイクロケラトームによって160μmの厚さで角膜実質層を切断しフラップを作製した後、フラップをめくり、エキシマレーザーで角膜実質層を削り取り、表面を整え、最後にフラップを元の位置に戻すレーシック(LASIK)法、アルコールを点眼し角膜表面を柔らかくさせ、マイクロケラトームを使わずに角膜上皮の50μmの厚さで切除してフラップを作製し、エキシマレーザーで角膜実質層を削り取り、表面を整え、最後にフラップを元の位置に戻すレーゼック(LASEK)法などの屈折矯正に有効である。  The use of the stratified epithelial cell sheet shown in the present invention is not limited at all, but for example, treatment of burns, scars, bruises, corneal erosions, corneal ulcers, etc., or excimer laser irradiation to the central part. The PRK method, which corrects myopia by reducing the refractive power of the cornea by reducing the refractive power of the cornea, cutting the corneal stroma layer with a thickness of 160 μm with a microkeratome, and then turning the flap, excimer laser With the LASIK method, the surface of the corneal layer is trimmed, the flap is returned to its original position, alcohol is applied to soften the corneal surface, and the thickness of the corneal epithelium is reduced to 50 μm without using a microkeratome. Cut the flap to create a flap, scrape off the corneal stroma with an excimer laser, trim the surface, and finally put the flap back in place This is effective for refractive correction such as the returning LASEC method.

以下に、本発明を実施例に基づいて更に詳しく説明するが、これらは本発明を何ら限定するものではない。  Hereinafter, the present invention will be described in more detail based on examples, but these do not limit the present invention in any way.

実施例1、2Examples 1 and 2

深麻酔下のウサギ角膜輪部から常法に従って角膜上皮組織を採取し、0.05%トリプシン処理することで得られた細胞を、図1に示すような温度応答性高分子が2.0μg/cm被覆されたセルカルチャーインサート上に播種した。細胞播種数及び使用した培地組成を図1に示す(37℃、5%CO下)。実施例1では、インサート下層にフィーダー細胞としてマイトマイシンC処理したNIH−3T3細胞を播種した。実施例2ではフィーダー細胞を使用しなかった。培養13日後のウサギ重層化角膜上皮細胞のようすをそれぞれ図2(実施例1)、図3(実施例2)に示す。いずれの場合もウサギ角膜上皮細胞はコンフルエントに達するまで増殖し、重層化した。次に、セルインサートを20℃、30分間冷却し、リング状のキャリアを用いてセルカルチャーインサート上のウサギ重層化角膜上皮細胞シートを剥離することを試みたところ、いずれの場合も剥離させることができた。ウサギ重層化角膜上皮細胞シートを剥離した際のようすをそれぞれ図4(実施例1)、図5(実施例2)に示す。さらに、剥離した細胞シートが重層化していることを確認するために、得られたウサギ重層化角膜上皮細胞シート切片を常法(H&E染色)に従い染色した。染色した結果をそれぞれ図6(実施例1)、図7(実施例2)に示す。いずれの場合も重層化していることが確認できた。Corneal epithelial tissue is collected from a rabbit corneal limbus under deep anesthesia according to a conventional method, and cells obtained by 0.05% trypsin treatment are treated with a temperature-responsive polymer as shown in FIG. It was plated in cm 2 coated cell culture on the insert. The cell seeding number and the medium composition used are shown in FIG. 1 (37 ° C., 5% CO 2 ). In Example 1, NIH-3T3 cells treated with mitomycin C were seeded as feeder cells in the lower layer of the insert. In Example 2, no feeder cells were used. The appearance of rabbit stratified corneal epithelial cells after 13 days of culture is shown in FIG. 2 (Example 1) and FIG. 3 (Example 2), respectively. In either case, rabbit corneal epithelial cells proliferated and reached stratification until they reached confluence. Next, the cell insert was cooled at 20 ° C. for 30 minutes, and an attempt was made to peel the rabbit stratified corneal epithelial cell sheet on the cell culture insert using a ring-shaped carrier. did it. The appearance when the rabbit stratified corneal epithelial cell sheet is peeled is shown in FIG. 4 (Example 1) and FIG. 5 (Example 2), respectively. Furthermore, in order to confirm that the detached cell sheet was stratified, the obtained rabbit stratified corneal epithelial cell sheet section was stained according to a conventional method (H & E staining). The dyeing results are shown in FIG. 6 (Example 1) and FIG. 7 (Example 2), respectively. In any case, it was confirmed that the layers were multi-layered.

比較例1Comparative Example 1

深麻酔下のウサギ角膜輪部から常法に従って角膜上皮組織を採取し、0.05%トリプシン処理することで得られた細胞を、温度応答性高分子が2.0μg/cm被覆された培養皿上に播種したこと以外は実施例1と同様に行った。その際、フィーダー細胞は使用しなかった。培養13日後にウサギ重層化角膜上皮細胞のようすを確認したが、ウサギ重層化角膜上皮細胞はコンフルエントに達するまで増殖したが重層化していなかった。Corneal epithelial tissue is collected from a rabbit corneal ring under deep anesthesia according to a conventional method, and cells obtained by 0.05% trypsin treatment are cultured with a temperature-responsive polymer coated at 2.0 μg / cm 2. The same procedure as in Example 1 was performed except that seeding was performed on a dish. At that time, feeder cells were not used. After 13 days of culture, the appearance of rabbit stratified corneal epithelial cells was confirmed, but the rabbit stratified corneal epithelial cells proliferated until they reached confluence but were not stratified.

実施例3、4Examples 3 and 4

献眼ヒト角膜輪部から常法に従って角膜上皮組織を採取し、0.05%トリプシン処理することで得られた細胞を、図8に示すような温度応答性高分子が1.9μg/cm被覆されたセルカルチャーインサート上に播種した。細胞播種数及び使用した培地組成を図8に示す(37℃、5%CO下)。実施例3では、インサート下層にフィーダー細胞としてマイトマイシンC処理したNIH−3T3細胞を播種した。実施例4ではフィーダー細胞を使用しなかった。培養14日後のヒト重層化角膜上皮細胞のようすをそれぞれ図9(実施例3)、図10(実施例4)に示す。いずれの場合もヒト角膜上皮細胞はコンフルエントに達するまで増殖し、重層化した。次に、セルインサートを20℃、30分間冷却し、リング状のキャリアを用いてセルカルチャーインサート上のヒト重層化角膜上皮細胞シートを剥離することを試みたところ、いずれの場合も剥離させることができた。ヒト重層化角膜上皮細胞シートを剥離した際のようすを図11(実施例4)に示す。さらに、剥離した細胞シートが重層化していることを確認するために、得られたヒト重層化角膜上皮細胞シート切片を常法(H&E染色)に従い染色した。染色した結果をそれぞれ図12(実施例3)、図13(実施例4)に示す。いずれの場合も重層化していることが確認できた。A corneal epithelial tissue is collected from a human corneal limbus according to a conventional method and treated with 0.05% trypsin, and a temperature-responsive polymer as shown in FIG. 8 is coated with 1.9 μg / cm 2. Seeded on the cultured cell culture inserts. The cell seeding number and the medium composition used are shown in FIG. 8 (37 ° C., 5% CO 2 ). In Example 3, NIH-3T3 cells treated with mitomycin C were seeded as feeder cells in the lower layer of the insert. In Example 4, no feeder cells were used. The appearance of human stratified corneal epithelial cells after 14 days of culture is shown in FIG. 9 (Example 3) and FIG. 10 (Example 4), respectively. In either case, human corneal epithelial cells proliferated and reached stratification until they reached confluence. Next, the cell insert was cooled at 20 ° C. for 30 minutes, and an attempt was made to peel off the human stratified corneal epithelial cell sheet on the cell culture insert using a ring-shaped carrier. did it. The appearance when the human stratified corneal epithelial cell sheet is peeled is shown in FIG. 11 (Example 4). Furthermore, in order to confirm that the detached cell sheet was stratified, the obtained human stratified corneal epithelial cell sheet section was stained according to a conventional method (H & E staining). The dyed results are shown in FIG. 12 (Example 3) and FIG. 13 (Example 4), respectively. In any case, it was confirmed that the layers were multi-layered.

比較例2Comparative Example 2

献眼ヒト角膜輪部から常法に従って角膜上皮組織を採取し、0.05%トリプシン処理することで得られた細胞を、温度応答性高分子が1.9μg/cm被覆された培養皿上に播種したこと以外は実施例3と同様に行った。その際、フィーダー細胞は使用しなかった。培養14日後にヒト重層化角膜上皮細胞のようすを確認したが、ヒト重層化角膜上皮細胞はコンフルエントに達するまで増殖したが重層化していなかった。Corneal epithelial tissue is collected from the donated human corneal limbus according to a conventional method, and cells obtained by 0.05% trypsin treatment are placed on a culture dish coated with a temperature-responsive polymer of 1.9 μg / cm 2. The same procedure as in Example 3 was performed except that seeding. At that time, feeder cells were not used. After 14 days of culture, the appearance of human stratified corneal epithelial cells was confirmed, but the human stratified corneal epithelial cells proliferated until they reached confluence but were not stratified.

本発明に記載される方法であれば、上皮系細胞を多孔膜上で培養することでフィーダー細胞を用いることなく重層化させられる。また、フィーダー細胞を細胞外マトリックスと共に培養することでフィーダー細胞を何ら変性させることなく上皮系細胞を重層化させられる。さらに、上記多孔膜上に温度応答性高分子を被覆すれば、冷却のみで重層化させた上皮系細胞を剥離させることができ、そのため生体組織への生着性が極めて高い高生着性の重層化上皮系細胞シートが得られるようになる。この方法で得られる重層化上皮系細胞シートは、たとえば角膜移植、皮膚移植、角膜疾患治療、近視治療等の臨床応用が強く期待される。したがって、本発明は細胞工学、医用工学、などの医学、生物学等の分野における極めて有用な発明である。  According to the method described in the present invention, epithelial cells are cultured on a porous membrane to be layered without using feeder cells. In addition, by culturing feeder cells with an extracellular matrix, epithelial cells can be stratified without any degeneration of the feeder cells. Furthermore, if a temperature-responsive polymer is coated on the porous membrane, the epithelial cells that have been stratified only by cooling can be detached, and therefore, a highly encapsulated stratification that has extremely high engraftment to living tissue. The epithelial cell sheet can be obtained. The stratified epithelial cell sheet obtained by this method is strongly expected to have clinical applications such as corneal transplantation, skin transplantation, corneal disease treatment, and myopia treatment. Therefore, the present invention is extremely useful in the fields of medicine, biology, etc., such as cell engineering and medical engineering.

実施例1、2に示す実施方法を示すものである。  The implementation method shown in Example 1, 2 is shown. 実施例1の培養13日後のウサギ重層化角膜上皮細胞のようすを示す写真である。  2 is a photograph showing the appearance of rabbit stratified corneal epithelial cells after 13 days of culture in Example 1. FIG. 実施例の培養13日後のウサギ重層化角膜上皮細胞のようすを示す写真である。  It is a photograph showing the appearance of rabbit stratified corneal epithelial cells after 13 days of culture in the examples. 実施例1のウサギ重層化角膜上皮細胞シートを剥離したようすを示す写真である。  2 is a photograph showing a state in which the rabbit stratified corneal epithelial cell sheet of Example 1 is peeled off. 実施例2のウサギ重層化角膜上皮細胞シートを剥離したようすを示す写真である。  2 is a photograph showing a state where the rabbit stratified corneal epithelial cell sheet of Example 2 is peeled off. 実施例1のウサギ重層化角膜上皮細胞シート切片をH&E染色ときのようすを示す写真である。  It is a photograph which shows the appearance when the rabbit stratified corneal epithelial cell sheet section of Example 1 is stained with H & E. 実施例2のウサギ重層化角膜上皮細胞シート切片をH&E染色ときのようすを示す写真である。  It is a photograph which shows the appearance when the rabbit stratified corneal epithelial cell sheet section of Example 2 is stained with H & E. 実施例3、4に示す実施方法を示すものである。  The implementation method shown in Example 3 and 4 is shown. 実施例3の培養14日後のヒト重層化角膜上皮細胞のようすを示す写真である。  2 is a photograph showing the appearance of human stratified corneal epithelial cells after 14 days of culture in Example 3. FIG. 実施例4の培養14日後のヒト重層化角膜上皮細胞のようすを示す写真である。  2 is a photograph showing the appearance of human stratified corneal epithelial cells after 14 days of culture in Example 4. FIG. 実施例4のヒト重層化角膜上皮細胞シートを剥離したようすを示す写真である。  It is a photograph which shows the state where the human stratified corneal epithelial cell sheet of Example 4 was peeled off. 実施例3のヒト重層化角膜上皮細胞シート切片をH&E染色ときのようすを示す写真である。  It is a photograph which shows the appearance when the human stratified corneal epithelial cell sheet section of Example 3 is stained with H & E. 実施例4のヒト重層化角膜上皮細胞シート切片をH&E染色ときのようすを示す写真である。  It is a photograph which shows the appearance when the human stratified corneal epithelial cell sheet section of Example 4 is stained with H & E.

Claims (16)

多孔膜上でフィーダー細胞を用いずに上皮系細胞を培養させる際、その多孔膜を境に上層部及び下層部の双方を培地で満たし、細胞が培養されている間は常に多孔膜を介して培地が下層から細胞に供給され、かつ当該培地に血清及び上皮成長因子が含まれることを特徴とする、上皮系細胞の重層化培養方法。 When culturing epithelial cells without using feeder cells on the porous membrane , both the upper layer and the lower layer are filled with the medium with the porous membrane as a boundary, and the cells are always passed through the porous membrane while the cells are being cultured. A layered culture method for epithelial cells, wherein the medium is supplied to the cells from the lower layer , and the medium contains serum and epidermal growth factor . 上皮系細胞が角膜上皮細胞、表皮角化細胞、口腔粘膜細胞、結膜上皮細胞である、請求項記載の上皮系細胞の重層化培養方法。 The method for stratifying culture of epithelial cells according to claim 1 , wherein the epithelial cells are corneal epithelial cells, epidermal keratinocytes, oral mucosal cells, and conjunctival epithelial cells. 上皮系細胞がヒト由来のものである、請求項1または2記載の上皮系細胞の重層化培養方法。 The method for stratifying culture of epithelial cells according to claim 1 or 2 , wherein the epithelial cells are derived from human. 多孔膜表面に水に対する上限もしくは下限臨界溶解温度が0〜80℃である温度応答性高分子を被覆し、その上で上皮系細胞が培養され、重層化させた後、
(1)培養液温度を上限臨界溶解温度以上または下限臨界溶解温度以下とし、
(2)培養した角膜上皮細胞シートまたはその重層化シートをキャリアに密着させ、
(3)そのままキャリアと共に剥離する
ことを特徴とする、請求項1〜3のいずれか1項記載の上皮系細胞の重層化培養方法。
After coating the surface of the porous membrane with a temperature-responsive polymer having an upper or lower critical solution temperature of 0 to 80 ° C. with respect to water, epithelial cells are cultured and layered,
(1) The culture solution temperature is set to the upper critical solution temperature or higher or the lower critical solution temperature or lower,
(2) Adhering the cultured corneal epithelial cell sheet or its multilayered sheet to a carrier,
(3) The method for stratifying culture of epithelial cells according to any one of claims 1 to 3, wherein the cells are peeled off together with the carrier.
温度応答性高分子が、ポリ(N−イソプロピルアクリルアミド)である、請求記載の上皮系細胞の重層化培養方法。 The layered culture method of epithelial cells according to claim 4 , wherein the temperature-responsive polymer is poly (N-isopropylacrylamide). キャリアの形状が中心部を切り抜いたリング状のものである、請求項4または5記載の上皮系細胞の重層化培養方法。 The method for stratifying culture of epithelial cells according to claim 4 or 5 , wherein the carrier has a ring shape with the center cut out. 剥離が蛋白質分解酵素による処理が施されていない、請求4〜6のいずれか1項記載の上皮系細胞の重層化培養方法。 The layered culture method of epithelial cells according to any one of claims 4 to 6, wherein the detachment is not treated with a proteolytic enzyme. 多孔膜がセルインサートであることを特徴とする、請求項1〜7のいずれか1項記載の上皮系細胞の重層化培養方法。 The layered culture method for epithelial cells according to any one of claims 1 to 7 , wherein the porous membrane is a cell insert. 請求項1〜のいずれか1項記載の方法で得られたフィーダー細胞を含まない重層化上皮系細胞シート。 A stratified epithelial cell sheet containing no feeder cells obtained by the method according to any one of claims 1 to 8 . 組織の一部或いは全部を損傷もしくは欠損した患部を治療するための、請求項の重層化上皮系細胞シート。 The stratified epithelial cell sheet according to claim 9 for treating an affected part in which a part or all of the tissue is damaged or missing. 組織が前眼部組織、皮膚組織、粘膜組織である、請求項10記載の重層化上皮系細胞シート。 The stratified epithelial cell sheet according to claim 10 , wherein the tissue is an anterior ocular tissue, skin tissue, or mucosal tissue. 患部に被覆する際、患部の大きさ、形状に沿って切断された、請求項10または11記載の重層化上皮系細胞シート。 The stratified epithelial cell sheet according to claim 10 or 11 , which is cut along the size and shape of the affected part when covering the affected part. 治療が両眼性の難治性角結膜疾患であることを特徴とする、請求項10〜12のいずれか1項記載の重層化上皮系細胞シート。 The stratified epithelial cell sheet according to any one of claims 10 to 12, wherein the treatment is a bilateral intractable keratoconjunctival disease. 治療が角膜びらん、角膜潰瘍であることを特徴とする、請求項10〜12のいずれか1項記載の重層化上皮系細胞シート。 The stratified epithelial cell sheet according to any one of claims 10 to 12 , wherein the treatment is corneal erosion or corneal ulcer. 治療がRK法、PRK法、LASIK法による屈折矯正であることを特徴とする、請求項10〜12のいずれか1項記載の重層化上皮系細胞シート。 The stratified epithelial cell sheet according to any one of claims 10 to 12, wherein the treatment is refractive correction by an RK method, a PRK method, or a LASIK method. 治療がLASEK法による屈折矯正であることを特徴とする、請求項10〜12のいずれか1項記載の重層化上皮系細胞シート。 The stratified epithelial cell sheet according to any one of claims 10 to 12, wherein the treatment is refractive correction by the LASEK method.
JP2003405201A 2003-10-28 2003-10-28 Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof Expired - Fee Related JP4874514B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003405201A JP4874514B2 (en) 2003-10-28 2003-10-28 Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003405201A JP4874514B2 (en) 2003-10-28 2003-10-28 Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011193339A Division JP2011250804A (en) 2011-09-05 2011-09-05 Method for culturing multilayered epithelial cell, multilayered epithelial cell sheet obtained by the same and use of the sheet

Publications (2)

Publication Number Publication Date
JP2005130838A JP2005130838A (en) 2005-05-26
JP4874514B2 true JP4874514B2 (en) 2012-02-15

Family

ID=34650192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003405201A Expired - Fee Related JP4874514B2 (en) 2003-10-28 2003-10-28 Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof

Country Status (1)

Country Link
JP (1) JP4874514B2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10533158B2 (en) * 2005-02-28 2020-01-14 Tokai University Educational System Cultured cell sheet, production method thereof, and application method thereof
JP4961547B2 (en) * 2005-12-14 2012-06-27 国立大学法人京都大学 A new evaluation system for drug effects on retinal neovascularization
WO2007103865A2 (en) * 2006-03-03 2007-09-13 Organogenesis, Inc. Oral tissue regeneration and repair
US20080003676A1 (en) * 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
KR100832592B1 (en) * 2006-08-17 2008-05-27 박현숙 Method for co-culture of stem cells and feeder cells using a polymer membrane
JP5181172B2 (en) * 2007-02-21 2013-04-10 国立大学法人富山大学 Method for producing cultured stratified epithelial sheet
JP5641669B2 (en) * 2007-03-14 2014-12-17 株式会社セルシード Cell surface protein repair method
US8557583B2 (en) 2007-03-15 2013-10-15 Dai Nippon Printing Co., Ltd. Cell culture support and manufacture thereof
JP5150150B2 (en) * 2007-07-03 2013-02-20 秀男 並木 Cell culture substrate and method for producing the same
EP2617438B1 (en) * 2010-09-15 2020-02-19 Tokyo Women's Medical University Middle ear mucous membrane-like cell sheet, production method therefor and utilization thereof
JPWO2018154813A1 (en) * 2017-02-24 2019-02-28 株式会社セルシード Tissue regeneration cultured cell sheet, production method and use thereof
WO2019189324A1 (en) * 2018-03-28 2019-10-03 公立大学法人横浜市立大学 Cell mass fusion method

Also Published As

Publication number Publication date
JP2005130838A (en) 2005-05-26

Similar Documents

Publication Publication Date Title
US10434219B2 (en) Method of treatment using corneal epithelium forming cell sheets
JP4475847B2 (en) Anterior segment-related cell sheet, three-dimensional structure, and production method thereof
JP4335873B2 (en) Regenerated corneal endothelial cell sheet, production method and use thereof
US9889228B2 (en) Cultured cell sheet, production method, and tissue repair method using thereof
US8642338B2 (en) Anterior ocular segment related cell sheets, three-dimensional structures, and processes for producing the same
JP2006320304A (en) Closed cell culture container and method for culturing cell with the container
JP4874514B2 (en) Method for stratifying culture of epithelial cells, stratified epithelial cell sheet obtained therefrom, and method of use thereof
JP5731728B2 (en) Sealed cell culture vessel and cell culture method using the same
JP3935096B2 (en) Highly engraftable corneal epithelial substitute cell sheet, production method and use thereof
JP5227223B2 (en) Cell culture support
JP2005000608A (en) Cultured cell sheet having high take capability and method for manufacturing and using the same
JP3935093B2 (en) Highly engrafted regenerative corneal epithelial cell sheet, production method and use thereof
JP2011250804A (en) Method for culturing multilayered epithelial cell, multilayered epithelial cell sheet obtained by the same and use of the sheet
JP5837530B2 (en) Sealed cell culture vessel and cell culture method using the same
JP5264799B2 (en) Anterior segment-related cell sheet, three-dimensional structure, and production method thereof
TW201839126A (en) Anterior eye part related cell sheet, three-dimensional structure, and methods for manufacturing same being recovered in states of a desmosome structure among cells and a basilar membrane protein between each cell and a substrate

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050915

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061024

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20061122

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20061122

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20061122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070920

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071119

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080117

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20080117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080225

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080603

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080804

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20081015

A912 Removal of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20081205

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110905

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110912

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111124

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141202

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4874514

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees